DiaMedica Therapeutics DMAC
NASDAQ DMAC
$8.27 +0.07 (+0.85%)
At close: Sep 30, 2026 · 4:00 PM EDT

DiaMedica Therapeutics (DMAC) FCF Margin (2018)

Updated

DiaMedica Therapeutics (DMAC) reported FCF Margin of -1149.20% for FY2018.

Analysis

DiaMedica Therapeutics (DMAC) FCF Margin (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 28.82%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 18.33%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 26.96%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 43.05%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 34.72%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 34.70%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 44.00%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 30.39%
10 DiaMedica Therapeutics 445.97 Mn 445.97 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 -371.80%
API Access

DiaMedica Therapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=DMAC&period=max&api_key=YOUR_API_KEY